Home » Topics » Regulatory » Patents

Patents
RSS

Novel compounds with potential in the treatment of metabolic disorders patented

Sep. 28, 2006

Recent patents describe new agents for diabetes and related disorders

Sep. 28, 2006

New retinoid RARgamma agonists claimed in recent Galderma patent

Sep. 28, 2006

Novel LXRbeta modulators prepared and tested at Wyeth

Sep. 27, 2006

Therapeutic agents for respiratory disorders described in recent patents

Sep. 27, 2006

Recent Pfizer and Solvay patents disclose new agents for schizophrenia and depression

Sep. 27, 2006

Novel 5-HT4 receptor agonists for gastrointestinal disorders emerge from Pfizer R&D

Sep. 26, 2006

Novel oncolytic drugs revealed in recent patents

Sep. 26, 2006

Novel antiinfective agents disclosed in recent patent literature

Sep. 26, 2006

Novel treatment option for lipoprotein disorders jointly reported by Negma-Lerads and CNRS

Sep. 22, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...